Metropolis Network Expansion and Revenue Growth Strategy
Q3FY24 Key Highlights
01
Core Business* Revenue grew at 12%
B2C revenues grew by 15%
02
33
03
B2B revenues grew by 7%
04
Premium Wellness grew@ 15%.
Specialized revenue grew @13% Y-o-Y
METROPOLIS
The Pathology Specialist
Core business revenues grew at 12% with 9% Patient volume growth and 3% RPP
growth. 11% on account of Test volume & 1% on account of RPT. Revenue were
impacted to the tune of 1% on account of floods in Chennai in Q3FY24.
B2C revenues grew by 15% for Q3FY24 Y-o-Y with Patient Volume growth of 13%
& RPP growth of 2%. B2C revenue in Mumbai grew by 18% on Y-o-Y basis
B2B revenues grew by 7% for Q3FY24 Y-o-Y with Patient Volume growth of 5% &
RPP growth of 2%
B2C Premium Wellness revenue grew at 15% Y-o-Y with test volume growth of
11% Y-o-Y. Revenue from specialized tests grew at 13% Y-o-Y for Q3FY24 with test
volume growth of 11% Y-o-Y
05
50
Expanding Network & scaling
productivity and profitability
06
90
10
07
Reported EBIDTA margins @ 22.5%
Digital Transformation undertaken for
Efficiency, Analytics and Customer Service
*Core business excludes revenue for Covid & Covid allied and PPP Contracts (incl. Hi-tech)
Company has opened 193 centers and 5 labs in Q3FY24 in line with it 90:30
program. In the last 9 months, added presence from 307 towns to 595 towns
EBIDTA before network expansion & one time impact taken in Provision for
doubtful debt (PDD) on account of Aam Aadmi Mohalla Clinic at 24.5%.
Dilution of ~120 bps is on account of Network expansion & 80 bps on account of
one-time impact of PDD
Witnessed substantial IT deployments aimed at enhancing efficiency and
productivity by leveraging data analytics, improving customer service, and
refining process management.
6View entire presentation